20396733|t|Effect of ultralow doses of antibodies to S-100 protein in animals with impaired cognitive function and disturbed emotional and neurological status under conditions of experimental Alzheimer disease.
20396733|a|Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system deficiency caused by subchronic treatment with scopolamine.
20396733	72	99	impaired cognitive function	Disease	MESH:D003072
20396733	181	198	Alzheimer disease	Disease	MESH:D000544
20396733	363	370	anxiety	Disease	MESH:D001007
20396733	395	412	Alzheimer disease	Disease	MESH:D000544
20396733	488	499	scopolamine	Chemical	MESH:D012601
20396733	Negative_Correlation	MESH:D012601	MESH:D000544

